Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: Biclonality versus intraclonal evolution of a single tumor cell clone

Haematologica

Volumn 91, Issue 3, 2006, Pages 331-339

  Sanchez, Maria Luz ^a,b   Almeida, Julia ^a,b   Lopez, Antonio ^a,b   Sayagues, Jose Maria ^a,b   Rasillo, Ana ^a,b   Sarasquete, Eugenia A ^c   Balanzategui, Ana ^c   Tabernero, Maria Dolores ^c   Diaz Mediavilla, Joaquin ^d   Barrachina, Carmen ^e   Paiva, Artur ^f   Gonzalez, Marcos ^g   San Miguel, Jesus F ^b,c   Orfao, Alberto ^a,b,c  

^a Servicio General de Citometria   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f Centro de Histocompatibilidade do Centro Coimbra   (Portugal)

^g NONE

Author keywords

B cell chronic lymphoproliferative disorders; Biclonality; FISH; Immunophenotype; Intraclonal evolution

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; CELL CLONE; CELL HETEROGENEITY; CHROMOSOME ABERRATION; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA CONTENT; FLUORESCENCE; GENE SEQUENCE; GENETIC DISORDER; GENETIC TRAIT; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LIGHT SCATTERING; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR CLONING; TUMOR CELL;

BASE SEQUENCE; CELL LINE, TUMOR; CLONE CELLS; CLONING, MOLECULAR; EVOLUTION, MOLECULAR; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR SEQUENCE DATA; PHENOTYPE;

EID: 33645416550     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fialkow PJ. Clonal and stem cell origin of blood cell neoplasms. In: Lobue J, Gordon AS, Silber R, Muggia FM, eds. Contemporary Hematology/Oncology. Plenum Publishing Corp., New York, 1980. p. 1-46.
2. Orfao A, Almeida J, ML Sanchez, JF San Miguel. Immunophenotypic diagnosis of leukemic B-cell chronic lymphoproliferative disorders other than CLL. In: GB Faguet, editors: Chronic lymphocytic leukemia: Molecular Genetics, Biology, Diagnosis and Management. Humana Press Inc. Totowa, New Jersey. 2003. p. 173-99.
3. Matutes E, Worner I, Sainati L, de Oliveira MP, Catovsky D. Advances in the lymphoproliferative disorders. Review of our experience in the study of over 1000 cases. Biol Clin Hematol 1989;11:53-62.
4. Matutes E, Owusu-Ankomah K, Morilla R, Garcia-Marco J, Houlihan A, Que TH, et al. The immunological profile of B-cell disorders: A proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-5.
5. Catovsky D. Chronic lymphoproliferative disorders. Curr Opin Oncol 1995;7: 3-11.
6. Montserrat E. Chronic lymphoproliferative disorders. Curr Opin Oncol 1997;9:34-41.
7. Cleary ML, Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 1984;2:489-93.
8. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac transplant recipients: clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984;310:477.
9. Schmitt-Graff A, Hummel M, Anagnostopoulos I, Stoltenburg G, Stein H. Primary brain lymphoma in acquired immunodeficiency syndrome. Immunophenotype and molecular pathologic characterization in stereotactic biopsy, autopsy and cerebrospinal fluid cytology. Pathologe 1995;16:75-80.
10. Armes JE, Angus P, Southey MC, Battaglia SE, Ross BC, Jones RM, et al. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer 1994;74:2436-41.
11. Sklar J, Cleary ML, Thielemans K, Gralow J, Warnke R, Levy R. Biclonal B-cell lymphoma. N Engl J Med 1984;311:20-7.
12. Siegelman MH, Cleary ML, Warnke R, Sklar J. Frequent biclonality and Ig gene alterations among B-cell lymphomas that show multiple histologic forms. J Exp Med 1985;161:850-63.
13. Hairman C, Vaeemans E, Carels D, Theunissen J, Van-Camp B, Theilemans K. Isotype switch and idiotype variation in hairy cell leukemia. Leukemia 1990;4:856-62.
14. Gonzalez-Campos J, Rios-Herranz E, De Blas-Orlando JM, Martin-Noya A, Parody-Ruiz-Berdejo R, Rodriguez-Fernandez JM. Chronic lymphocytic leukemia with two cellular populations: a biphenotypic or biclonal disease. Ann Hematol 1997;74:243-6.
15. Wong KF, So CC. Biclonal B-cell chronic lymphocytic leukemia with inv(14) (q11q32). Cancer Genet Cytogenet 1997;94:135-7.
16. Fend F, Quintanilla-Martínez L, Kumar S, Beaty MW, Blum L, Sorbara L, et al. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. Am J Pathol 1999;154:1857-66.
17. Duque RE, Everett ET, Iturraspe J. Biclonal composite lymphoma. A multiparameter flow cytometric analysis. Arch Pathol Lab Med 1990;114:176-9.
18. Gine E, Bosch F, Villamor N, Rozman M, Colomer D, Lopez-Guillermo A, et al. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association? Leukemia 2002;16:1454-9.
19. Sanchez ML, Almeida J, Gonzalez D, Gonzalez M, Garcia-Marcos MA, Balanzategui A, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 2003;102:2994-02.
20. Cerny J, Slavickova A, Krepelova A, Tmeny M, Karban J, Klener P. Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications. J Cell Physiol 2004;199:217-26.
21. Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, et al. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
22. Sanchez ML, Almeida J, Vidriales MB, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ, et al. Incidence of phenotypic aberrations in a series of 467 patients with B-chronic lymphoproliferative disorders: basis for the design of specific 4-color stainings to be used for minimal residual disease investigation. Leukemia 2002;16:1460-9.
23. Triolo R, Omede P, Giaretta F, Ravaglia R, Battaglio S, Palumbo A, et al. Cytofluorimetric evaluation of plasma cell proliferative activity in monoclonal gammopathies. Eur J Histochem 1997;41 Suppl 2:57-8.
24. Tabernero MD, San Miguel JF, Garcia-Sanz R, Najera L, Garcia-Isidoro M, Perez-Simon JA, et al. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes. Am J Pathol 1996;149:153-61.
25. Sayagues JM, Tabernero MD, Maillo A, Diaz P, Rasillo A, Bortoluci A, et al. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes. Cytometry 2002;50:153-9.
26. Gonzalez D, Balanzategui A, Garcia-Sanz R, Gutierrez N, Seabra C, van Dongen JJ, et al. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications. Leukemia 2003;17:1398-403.
27. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
28. Lopez-Perez R, Garcia-Sanz R, Gonzalez D, Balanzategui A, Chillon MC, Alaejos I, et al. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001;28:665-72.
29. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995;16:237-42.
30. Lefranc MP. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 2001;29:207-9.
31. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. Diagnosis criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325-32.
32. Marti GE, Carter P, Abbasi F, Washington GC, Jain N, Zenger VE, et al. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom 2003;52:1-12.
33. Rawstron AC. Prevalence and characteristics of monoclonal B-cell lymphocytosis (MBL) in healthy individuals and the relationship with clinical disease. J Biol Regul Homeost Agents 2004;18:155-60.
34. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. Text A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002;346:564-9.
35. Hubbard SM, Chabner BA, DeVita VT, Simon R Jr, Berard R, Jones B, et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982;59:258.
36. Acker B, Hoppe T, Colby TV, Cox RS, Haplan HS, Rosenberg SA. Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983;1:11.